Romaco: System Solution with Patented In-Line Scale
At the forthcoming POWTECH 2014, Romaco Kilian will show the Kilian KTP 420X tablet press with the patented in-line continuous weight control (CWC). The engineering specialist’s new KTP 420X series is an innovative generation of flexible, high speed tablet presses for the pharmaceutical industry.
The Romaco Kilian KTP 420X is a versatile, high speed tablet press which, in combination with the new CWC system, will be Romaco’s highlight at this year’s POWTECH. This groundbreaking machine, equipped with numerous patented features, compresses up to 360,000 tablets an hour. The Kilian KTP 420X is ideal for the production of mono-layer, bi-layer or core tablets (tab-in-tab), and it can also be used to process poorly flowing materials. It is characterised by high effective availability, low costs for maintenance and spare parts and very simple handling. The Kilian KTP 420X is winner of this year’s iF Award for innovative design.
Patented Features
The patented CWC in-line scale allows the weight of the tablet being produced to be measured continuously at the discharge as the products are pressed without destroying them. The KTP 420X makes Romaco Kilian the first manufacturer worldwide to offer a solution for continuous weight control. The weighed tablets are placed in the “good” channel using compressed air. As a result of the new process, there is no longer any need to make sample tablets to check the weight and product loss is reduced to zero. This automatic weight control system helps to avoid unnecessary costs, especially when processing expensive (active) ingredients.
One tablet is measured per turret revolution with an accuracy of 0.1 mg. The CWC system is fully integrated in the PLC and operated over the HMI (human machine interface) panel. The results of the measurements can be leveraged directly to control the machine and greatly improve the reliability of the process. CWC can be supplied as an option for all models in the KTP 420X and KTP 720X series and is also available as a retrofit kit.
High Flexibility and Low Total Cost of Ownership
The wear-free torque motor, extremely durable compression rollers and wear-free lower punch brakes with patented magnets underlie the very low total cost of ownership. The likewise patented punch bellows protect the tablets from lubricants. Thanks to the hermetic separation of the compaction and service areas, no product or oil gets into the machine compartment of the press. The optimised hygienic design permits quick and easy cleaning. At the same time the new, ergonomic, Windows 7 based HMI panel guarantees reliable handling. The significant reduction in press noise adds to the user friendly working environment.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance